GRALISE

Generic: GABAPENTIN

Manufacturer: Almatica Pharma Llc

Nonsteroidal Anti-inflammatory Drug [EPC]Benzodiazepine [EPC]Corticosteroid [EPC]Proton Pump Inhibitor [EPC]Provitamin D2 Compound [EPC]
285,248
Total Reports
105,774
Serious Reports
28,104
Death Reports
30
Reported Reactions
Death Report Ratio: High (9.85%)

Patient Demographics

Male
92,802
Female
167,645

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for GRALISE.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 22,859
7.3%
2 FATIGUE 20,471
6.6%
3 NAUSEA 17,742
5.7%
4 OFF LABEL USE 16,664
5.4%
5 PAIN 16,301
5.2%
6 DIARRHOEA 14,661
4.7%
7 HEADACHE 13,958
4.5%
8 DIZZINESS 12,752
4.1%
9 FALL 12,107
3.9%
10 DYSPNOEA 11,037
3.5%
11 VOMITING 9,409
3.0%
12 DEATH 9,359
3.0%
13 ARTHRALGIA 9,223
3.0%
14 ASTHENIA 9,176
2.9%
15 PAIN IN EXTREMITY 9,017
2.9%
16 MALAISE 8,456
2.7%
17 PNEUMONIA 8,147
2.6%
18 ANXIETY 7,534
2.4%
19 SOMNOLENCE 7,475
2.4%
20 DEPRESSION 7,146
2.3%
21 RASH 7,144
2.3%
22 BACK PAIN 7,130
2.3%
23 INSOMNIA 7,030
2.3%
24 PRODUCT USE IN UNAPPROVED INDICATION 6,915
2.2%
25 DRUG HYPERSENSITIVITY 6,879
2.2%
26 WEIGHT DECREASED 6,793
2.2%
27 CONDITION AGGRAVATED 6,647
2.1%
28 FEELING ABNORMAL 6,435
2.1%
29 GAIT DISTURBANCE 6,430
2.1%
30 CONSTIPATION 6,400
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.